Volume 7,Issue 1
A Comparative Review of the Efficacy of Laparoscopic Partial versus Total Adrenalectomy in the Treatment of Primary Aldosteronism Abstract
Primary aldosteronism (PA) is a leading cause of secondary hypertension, with radical treatment relying primarily on adrenal adenoma resection. Laparoscopic partial adrenalectomy (LPA) and total adrenalectomy (LTA) are the two mainstream surgical approaches in clinical practice. LPA has unique merits in preserving adrenal function, whereas LTA ensures more reliable therapeutic outcomes in specific cases by achieving complete lesion removal. This paper systematically reviews clinical evidence regarding the therapeutic efficacy, safety profiles, and postoperative hormonal function recovery of the two procedures. Integrating advancements in robot-assisted surgical technologies, it further discusses their respective indications and postoperative management strategies, aiming to provide a scientific foundation for individualized clinical decision-making.
[1] Hu X, Arthur Vithran DT, Yang Z, et al., 2025, Ectopic Adrenocortical Adenoma Causing Malignant Hypertension and Hypokalemia. Am J Case Rep, 26: e948022.
[2] Zennaro MC, Boulkroun S, Fernandes-Rosa FL, 2020, Pathogenesis and Treatment of Primary Aldosteronism. Nat Rev Endocrinol, 16(10): 578-589.
[3] Liu JH, Wei XD, Fu CC, et al., 2020, Long-Term Results of Laparoscopic Partial Versus Total Adrenalectomy for Aldosterone Producing Adenoma. Urol J, 17(4): 4981.
[4] Li KP, Duan X, Yang XS, et al., 2021, Partial Versus Total Adrenalectomy for the Treatment of Unilateral Aldosterone-Producing Adenoma: A Systematic Review and Meta-Analysis. Updates Surg, 73(6): 2301-2313.
[5] Billmann F, Billeter A, Thomusch O, et al., 2021, Minimally Invasive Partial Versus Total Adrenalectomy for Unilateral Primary Hyperaldosteronism: A Retrospective, Multicenter Matched-Pair Analysis Using the New International Consensus on Outcome Measures. Surgery, 169(6): 1361-1370.
[6] Gan L, Peng L, Li J, et al., 2022, Comparison of the Effectiveness and Safety of Robotic-Assisted and Laparoscopic in Adrenalectomy: A Systematic Review and Meta-Analysis. Int J Surg, 105: 106853.
[7] Knežević N, Penezić L, Kuliš T, et al., 2022, Senhance Robot-Assisted Adrenalectomy: A Case Series. Croat Med J, 63(2): 197-201.
[8] Ren R, Han H, Ma J, et al., 2024, Glucocorticoid Replacement Therapy After Retroperitoneal Laparoscopic Unilateral Adrenal Adenoma Resection in Patients with Non-Cortisol Secreting Tumors: A Retrospective Cohort Study. Gland Surg, 13(11): 2189-2197.
[9] Artiles Medina A, Gómez Dos Santos V, Mínguez Ojeda C, et al., 2025, The Role of Adrenal-Sparing Surgery in the Management of Aldosterone-Producing Adenoma: A Systematic Review and Meta-Analysis. Eur J Endocrinol, 193(3): S36-S52.
[10] Coco D, Leanza S, 2025, Robotic Adrenalectomy: A Comprehensive Review of Perioperative Outcomes, Comparative Efficacy, and Technological Advancements. J Robot Surg, 19(1): 659.
[11] Guo RQ, Li YM, Li XG, 2021, Comparison of the Radiofrequency Ablation Versus Laparoscopic Adrenalectomy for Aldosterone-Producing Adenoma: A Meta-Analysis of Perioperative Outcomes and Safety. Updates Surg, 73(4): 1477-1485.
[12] Brown JM, Honzel B, Tsai LC, et al., 2025, Characterizing the Origins of Primary Aldosteronism. Hypertension, 82(2): 306-318.
[13] Xue Y, Li X, Tang Y, et al., 2024, Patient Satisfaction Analysis of Robot-Assisted Minimally Invasive Adrenalectomy: A Single-Center Retrospective Study. J Robot Surg, 18(1): 39.
[14] Carling T, LaRue M, 2025, Improved and Individualized Approach to Adrenal Surgery. Endocr Relat Cancer, 32(7).
[15] Hartmann I, Hruska F, Vaclavik J, et al., 2022, Hypertension Outcomes of Adrenalectomy for Unilateral Primary Aldosteronism. Endocrine, 76(1): 142-150.